Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.524,21
-1,73%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vericel Corporation (VCEL) Vericel Corporation (VCEL) Notizie

Vericel Corporation

VCEL
56,50
1,55 (2,82%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202416:37EDGAR2Form 144 - Report of proposed sale of securities
03/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202421:14EDGAR2Form 144 - Report of proposed sale of securities
25/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:26EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:11EDGAR2Form 144 - Report of proposed sale of securities
14/11/202412:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:29EDGAR2Form 144 - Report of proposed sale of securities
13/11/202422:09EDGAR2Form 144 - Report of proposed sale of securities
12/11/202418:42EDGAR2Form 144 - Report of proposed sale of securities
07/11/202414:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:01EDGAR2Form 8-K - Current report
07/11/202413:55GLOBEVericel Reports Third Quarter 2024 Financial Results
24/10/202414:30GLOBEVericel to Report Third-Quarter 2024 Financial Results on..
21/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202422:27EDGAR2Form 144 - Report of proposed sale of securities
16/10/202422:43EDGAR2Form 144 - Report of proposed sale of securities
16/10/202422:31EDGAR2Form 144 - Report of proposed sale of securities
04/10/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:54EDGAR2Form 144 - Report of proposed sale of securities
02/10/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202419:16EDGAR2Form 144 - Report of proposed sale of securities
20/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:10EDGAR2Form 144 - Report of proposed sale of securities
13/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:16EDGAR2Form 144 - Report of proposed sale of securities
11/9/202422:55EDGAR2Form 144 - Report of proposed sale of securities
05/9/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202416:25EDGAR2Form 144 - Report of proposed sale of securities
03/9/202419:27EDGAR2Form 144 - Report of proposed sale of securities
29/8/202415:17GLOBEVericel to Present at the Morgan Stanley Global Healthcare..
26/8/202414:03EDGAR2Form 8-K - Current report
26/8/202413:45GLOBEVericel Announces FDA Approval and Commercial Availability..
16/8/202422:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
16/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202423:03EDGAR2Form 144 - Report of proposed sale of securities
15/8/202422:08EDGAR2Form 8-K - Current report
15/8/202422:05GLOBEVericel Announces FDA Approval of NexoBrid for the Treatment..
14/8/202422:17EDGAR2Form 144 - Report of proposed sale of securities
09/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:11EDGAR2Form 144 - Report of proposed sale of securities
07/8/202414:30GLOBEVericel to Present at the Canaccord Genuity Growth..
01/8/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202414:04EDGAR2Form 8-K - Current report
Apertura: 54,40 Min: 54,32 Max: 57,22
Chiusura: 54,95

La tua Cronologia

NASDAQ
VCEL
Vericel
NASDAQ
FICS
First Trust Internationa...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network